Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non-Alcoholic Fatty Liver Disease (NAFLD)

NCT03245606 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.

NCT NCT03245606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03245606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
Lead sponsor
Rennes University Hospital
Phase
Observational
Overall status
Completed
Start date
December 7, 2017
Completion date
July 7, 2020
Enrollment
270 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

non-alcoholic fatty liver disease